Angie B. Dull

Ty1 Defect in Proteolysis at High Temperature

Joseph F. Lawler, Daniel P. Haeusser, Angie B. Dull et al. · Journal of Virology · 2002 · 34 citations · Full text

High‐Content Fluorescence‐Based Screening for Epigenetic Modulators

Elisabeth D. Martínez, Angie B. Dull, John A. Beutler et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2006 · 27 citations

Epigenetic Modulators, Natural Sciences, Medicine +5

Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers

Deborah Wilsker, Allison Barrett, Angie B. Dull et al. · Clinical Cancer Research · 2019 · 26 citations · Full text

An estrogen receptor chimera senses ligands by nuclear translocation

Elisabeth D. Martinez, Geetha Vani Rayasam, Angie B. Dull et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2005 · 22 citations

Signal Transduction, Hormonal Receptor, Receptor (Biochemistry) +4

Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug—induced DNA double strand breaks from DNA double strand breaks associated with apoptosis

Angie B. Dull, Deborah Wilsker, Melinda G. Hollingshead et al. · Oncotarget · 2018 · 21 citations · Full text

Tumor Cell Dsbs, Tumor Growth Delay, Apoptosis +18